Menu IR Home IR Home News Releases Events and Presentations Stock Information Stock Quote Interactive Stock Chart Key Ratios Analyst Coverage FAQs Financials and SEC Filings Annual Reports and Proxies Quarterly Financial Reports SEC Filings Corporate Governance Documents and Charters Management Board of Directors Committee Composition Contact the Board Contact Us News Releases Investor Alerts Year All Years 2020 2019 2018 2017 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Aug 12, 2019 Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial of IMU-838 for the Treatment of Patients with Primary Sclerosing Cholangitis - Study Being Conducted in Collaboration with Investigators at Arizona State University and the Mayo Clinic - Aug 8, 2019 Immunic, Inc. Reports Second Quarter 2019 Financial Results and Highlights Recent Activity Aug 1, 2019 Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research in Support of the InnoMuNiCH Project Jul 30, 2019 Immunic, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference on August 8 Jul 16, 2019 Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer Show 5102550100 per page«1…67891011121314»
